News

Physician's Weekly2h
New Framework Reclassifies Nearly 20 Percent of People as Having Obesity
The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than ...
The Highland County Press7h
Ohio State introduces innovative weight loss program for obese patients that need a kidney transplant
New data from The Ohio State University Wexner Medical Center Comprehensive Transplant Center shows obese patients with end stage kidney disease and diabetes can safely use weight loss injections to ...
Creators Syndicate on MSN13h
Ex-Dem Rep: The N-Word Causes Cancer
Bowman, appearing last week as a panelist on MSNBC, said, "The reason why heart disease and cancer and obesity and diabetes ...
sharewise15h
Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?
Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...
MetaVia Inc.: MetaVia Doses First Patient in the 48 mg MAD Cohort of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity to Further Explore Maximum ...
Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...
Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo ...
Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...
Should Obesity be Classified as a Disease?
To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...